A Prospective, Post Marketing Observational Study to Evaluate the Safety of Pletaal SR Capsule

Trial Profile

A Prospective, Post Marketing Observational Study to Evaluate the Safety of Pletaal SR Capsule

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cilostazol (Primary)
  • Indications Cerebral infarction; Embolism and thrombosis
  • Focus Adverse reactions
  • Acronyms PLT SR PMOS
  • Sponsors Korea Otsuka Pharmaceutical
  • Most Recent Events

    • 11 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top